These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 921812)

  • 1. Monoamine oxidase inhibition in brain and liver produced by beta-carbolines: structure-activity relationships and substrate specificity.
    Buckholtz NS; Boggan WO
    Biochem Pharmacol; 1977 Nov; 26(21):1991-6. PubMed ID: 921812
    [No Abstract]   [Full Text] [Related]  

  • 2. Tetrahydro-beta-carbolines: specific inhibitors of type A monoamine oxidase in rat brain.
    Meller E; Friedman E; Schweitzer JW; Friedhoff AJ
    J Neurochem; 1977 May; 28(5):995-1000. PubMed ID: 864473
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of tetrahydro-beta-carbolines on monoamine oxidase and serotonin uptake in mouse brain.
    Buckholtz NS; Boggan WO
    Biochem Pharmacol; 1976 Oct; 25(20):2319-31. PubMed ID: 985563
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of substrate in the inhibition of rat liver and brain monoamine oxidase.
    Fuller RW
    Arch Int Pharmacodyn Ther; 1968 Jul; 174(1):32-7. PubMed ID: 4386711
    [No Abstract]   [Full Text] [Related]  

  • 5. Biochemistry and pharmacology of tryptamines and beta-carbolines. A minireview.
    McKenna DJ; Towers GH
    J Psychoactive Drugs; 1984; 16(4):347-58. PubMed ID: 6394730
    [No Abstract]   [Full Text] [Related]  

  • 6. [Monoamine oxidase. 12. Substrate specificity of monoamine oxidase in the rabbit brain and liver].
    Nabatame E
    Nihon Yakurigaku Zasshi; 1971 Jul; 67(4):374-86. PubMed ID: 5165262
    [No Abstract]   [Full Text] [Related]  

  • 7. Formanilide inhibition of rat brain monoamine oxidase.
    Urbaneja M; Knowles CO
    Gen Pharmacol; 1979; 10(4):309-14. PubMed ID: 488665
    [No Abstract]   [Full Text] [Related]  

  • 8. Tetrahydro-beta-carbolines and corresponding tryptamines: In vitro inhibition of serotonin, dopamine and noradrenaline uptake in rat brain synaptosomes.
    Komulainen H; Tuomisto J; Airaksinen MM; Kari I; Peura P; Pollari L
    Acta Pharmacol Toxicol (Copenh); 1980 Apr; 46(4):299-307. PubMed ID: 7368949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deamination of 5-methoxytryptamine, serotonin and phenylethylamine by rat MAO in vitro and in vivo.
    Prozialek WC; Vogel WH
    Life Sci; 1978 Feb; 22(7):561-9. PubMed ID: 272480
    [No Abstract]   [Full Text] [Related]  

  • 10. Monoamine oxidase inhibitors in South American hallucinogenic plants: tryptamine and beta-carboline constituents of ayahuasca.
    McKenna DJ; Towers GH; Abbott F
    J Ethnopharmacol; 1984 Apr; 10(2):195-223. PubMed ID: 6587171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further studies of the monoamine oxidase inhibiting activity of formanilides and formamidines.
    Benezet HJ; Knowles CO
    Gen Pharmacol; 1980; 11(4):357-60. PubMed ID: 7399253
    [No Abstract]   [Full Text] [Related]  

  • 12. The metabolism of indolealkylamines by type A and B monoamine oxidase of brain.
    Neff NH; Yang HY; Goridis C; Bialek D
    Adv Biochem Psychopharmacol; 1974; 11(0):51-8. PubMed ID: 4845688
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition by beta-carbolines of monoamine uptake into a synaptosomal preparation: structure-activity relationships.
    Buckholtz NS; Boggan WO
    Life Sci; 1977 Jun; 20(12):2093-9. PubMed ID: 18641
    [No Abstract]   [Full Text] [Related]  

  • 14. Monoamine oxidase inhibition by beta-carbolines: a quantum chemical approach.
    Tomás F; Aulló JM
    J Pharm Sci; 1979 Jun; 68(6):772-6. PubMed ID: 458582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procaine hydrochloride as a monoamine oxidase inhibitor: implications for Geriatric therapy.
    Fuller RW; Roush BW
    J Am Geriatr Soc; 1977 Feb; 25(2):90-3. PubMed ID: 833415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. beta-Carbolines as selective monoamine oxidase inhibitors: in vivo implications.
    Glover V; Liebowitz J; Armando I; Sandler M
    J Neural Transm; 1982; 54(3-4):209-18. PubMed ID: 7130973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of tryptolines (1, 2, 3, 4-tetrahydro-beta-carbolines) on monoamine metabolism and the platelet aggregation response in human platelets.
    Youdim MB; Oppenheim B
    Neuroscience; 1981; 6(4):801-10. PubMed ID: 7242917
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the selective inhibition by alpha-substituted tryptamine derivatives of the enzymatic deamination of serotonin].
    Gorkin VZ; Tat'ianenko LV; Suvorov NN; Nekliudov AD
    Biokhimiia; 1967; 32(5):1036-46. PubMed ID: 5599890
    [No Abstract]   [Full Text] [Related]  

  • 19. Selectivity of an indole-hydrazide derivative as inhibitor of mouse brain type A monoamine oxidase.
    Gurpegui M; Monge A; Fuentes JA
    Arzneimittelforschung; 1981; 31(10):1710-2. PubMed ID: 7198447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substrate-selective and tissue-selective inhibition of monoamine oxidase.
    Fuller RW; Roush BW
    Arch Int Pharmacodyn Ther; 1972 Aug; 198(2):270-6. PubMed ID: 5054735
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.